First human tests begin for new diabetes shot
NCT ID NCT07489482
Summary
This is an early-stage study to understand how the body processes and tolerates different versions of an experimental injection called SHR-3167, which is being developed for diabetes. The study will enroll 60 healthy volunteers to compare how much of the drug gets into the bloodstream and to check for side effects. The main goal is to gather basic safety and absorption data, not to treat diabetes in this trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiangya Hospital, Central South University
Changsha, Hunan, 410008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.